China's Creat Is Said to Edge Closer to U.S. Deal on Biotest

(Bloomberg) -- China’s Creat Group Corp. is making progress in securing approval from the U.S. government for its proposed acquisition of German blood plasma supplier Biotest AG as a deadline looms...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.